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Leishmania parasites are exposed to pronounced 
changes in their environment during their life cycle as 
they migrate from the sandtly midgut to the insect pro-
boscis and then into the phagolysosomes of the verte-
brate macrophages. The developmental transformations 
that produce each life cycle stage of the parasite may be 
signaled in part by binding of environmental ligands to 
receptors which mediate transduction of extracellular 
signals. We have identified a family of five clustered 
genes in Leishmania donovani which may encode signal 
transduction receptors. The coding regions of two of 
these genes, designated rae-A and rae-B, have been se-
quenced and shown to code for proteins with an NH2 -
terminal hydrophilic domain, an intervening putative 
transmembrane segment, and a COOH-terminal domain 
that has high sequence identity to the catalytic domain 
from adenylate cyclases in other eukaryotes. We have 
expressed the receptor-adenylate cyclase protein (RAC)-
A protein in Xenopus oocytes and demonstrated that it 
functions as an adenylate cyclase. Although RAC-B ex-
hibits no catalytic activity when expressed in oocytes, 
co-expression of HAC-A and HAC-B negatively regulates 
the adenylate cyclase activity of HAC-A, suggesting that 
these two proteins interact in the membrane. Further-
more, a truncated version of HAC-A functions as a dom-
inant negative mutant that inhibits the catalytic activ-
ity of the wild type receptor. The rae-A and rae-B genes 
encode developmentally regulated mRNAs which are ex-
pressed in the insect stage but not in the mammalian 
host stage of the parasite life cycle. 
Parasitic protozoa of the genus Leishmania experience 
markedly different environments as they transit through their 
life cycle. Promastigotes live in the midgut of the sandfly vec-
tor, infectious metacyclic parasites reside in the mouthparts of 
the insect, and amastigotes live within the acidic phagolysoso-
mal vesicles of the vertebrate host macrophages (1). As the 
parasite migrates from the midgut to the mouthparts of the 
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sandfly and subsequently into the phagolysosomes of the 
macrophage, it must be able to sense its changing extracellular 
milieu and respond by initiating a developmental transforma-
tion that culminates with the establishment of each successive 
life cycle stage. Although the factors that induce these devel-
opmental transformations are not fully understood, it seems 
likely that some environmental signals will act via binding of 
ligands to specific receptors in the parasite membrane which 
transduce the extracellular signal to the interior of the cell. 
However, to date no such ligands or their receptors have been 
identified in Leishmania parasites. 
Nonetheless, a body of evidence suggests that the second 
messenger cAMP is probably involved in signal transduction 
events and in life cycle transformations in Leishmania and in 
other related kinetoplastid protozoa. Thus, various life cycle 
stages contain significantly different intracellular concentra-
tions of cAMP in the related parasites Trypanosoma brucei (2) 
and in Trypanosoma cruzi (3). Furthermore, cAMP analogs and 
inhibitors of cAMP phosphodiesterase promote the in vitro 
differentiation of non-infectious insect stage epimastigotes ofT. 
cruzi into infectious metacyclic trypomastigotes ( 4), whereas 
such reagents inhibit the transformation of amastigotes of 
Leishmania donovani into promastigotes (5, 6) or of long slen-
der bloodstream forms ofT. brucei into short stumpy forms that 
are infectious to the insect (7). Perhaps the strongest case for 
the involvement of cAMP in the differentiation ofkinetoplastid 
parasites is the observation that peptides which are digestion 
products of vertebrate a-globin, and which are found in the gut 
of the triatomid insect vector following a blood meal, will acti-
vate a membrane-bound adenylate cyclase in non-infectious 
epimastigotes of T. cruzi and promote the differentiation of 
these epimastigotes into infectious metacyclic trypomastigotes 
in vitro (8). These results underscore the importance for para-
site development of environmental ligands which probably bind 
to receptors and activate adenylate cyclase. 
Although the cognate ligands and receptors involved in such 
signaling processes have not been identified for any of these 
kinetoplastid protozoa, a family of genes encoding adenylate 
cyclases have been cloned in T. brucei (9) and in the related 
parasite T. equiperdum (10). The proteins encoded by these 
genes possess a large extracellular hydrophilic NH2-terminal 
domain which is separated by a putative transmembrane seg-
ment from a COOH-terminal domain that bears high sequence 
homology to the catalytic domains of adenylate cyclases from 
other eukaryotes. These trypanosome genes have been ex-
pressed in Saccharomyces cerevisiae where they complement a 
temperature-sensitive defect in the yeast adenylate cyclase (10, 
11). The structural organization of these trypanosome proteins 
suggests that they may be receptors whose NH2-terminal do-
mains bind specific extracellular ligands that activate the in-
tracellular adenylate cyclase domain. This suggestion is rein-
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forced by the structural similarity between these trypanosome 
proteins and several well-characterized receptors from higher 
eukaryotes (12). Thus, mammalian atrial natriuretic peptide 
receptors bind their ligands via their NH2-terminal extracellu-
lar domains and activate the cytoplasmic guanylate cyclase 
domain (13, 14). However, ligands for these putative trypano-
some receptors have not yet been identified, and their specific 
role in signal transduction is currently unknown. 
The probable role of cAMP in life cycle transformations in 
kinetoplastid protozoa has led us to investigate adenylate cy-
clases in L. donovani. In this paper, we demonstrate that L. 
donovani parasites contain a family of genes that encode pu-
tative receptor-adenylate cyclases (RACs)1 that are structur-
ally very similar to the predicted proteins described in T. brucei 
and T. equiperdum. Five of these genes are arranged in a 
cluster in the L. donovani genome and are expressed as 
mRNAs of different sizes. One of these genes have been ex-
pressed in Xenopus oocytes and shown to encode a protein that 
functions as an adenylate cyclase. These results open the way 
to investigating the role of the Leishmania RAC proteins in 
signal transduction and their possible involvement in the life 
cycle transformations of this parasite. Studies on the RAC 
proteins of the intracellular Leishmania parasites may provide 
interesting parallels and distinctions compared to the RAC 
proteins identified in the extracellular parasites T. brucei and 
T. equiperdum. 
EXPERIMENTAL PROCEDURES 
Growth of Parasites and Isolation of Nucleic Acids-Promastigotes of 
either the DI700 (15) or the LV9 strain of L. donouani were cultured in 
Dulbecco's modified Eagle's-L medium (15) containing 5% heat-inacti-
vated fetal calf serum (Life Technologies, Inc.) and 5% bovine embryonic 
fluid (Sigma) at 27 °C. For preparation of LV9 amastigotes, J774-G8 
macrophage-like cells were cultured in plastic tissue culture flasks 
containing RPMI medium supplemented with 20 mM HEPES (Sigma), 
pH 7.3, and 20% heat-inactivated fetal calf serum at 37 oc in the 
presence of 5% C02 and were infected with promastigotes at a multi-
plicity of -10 parasites/cell. After 24 h the medium and remaining 
promastigotes were aspirated, the adherent cells were washed twice 
with sterile phosphate-buffered saline, fresh medium was added to the 
culture, and the infection was continued for a further 24 h. Cells were 
removed from the tissue culture flask by scraping with a rubber police-
man and were lysed by passage through a 30-gauge needle 20 times to 
achieve -95% breakage of cells, as monitored by staining with Trypan 
Blue. The liberated amastigotes were purified on a Percoll gradient as 
described (16), and RNA was prepared immediately. Total parasite RNA 
was prepared by the guanidinium isothiocyanate-phenol method (17). 
Polymerase Chain Reaction-Degenerate oligonucleotides were pur-
chased from Oligos Etc. and utilized in the PCR to amplify regions of the 
adenylate cyclase conserved catalytic domain from genomic DNA of L. 
donouani. The conserved peptide sequences and the oligonucleotides 
(bases in parentheses represent degenerate positions) designed from 
them were: peptide 1, TLIFTDI; oligonucleotide 1, AC(T/G/CJCT(T/C/ 
G)AT(TIC)TT(T/CJAC(T/G/C)GA(T/C)AT; peptide 2, EVKTVGD; oligo-
nucleotide 2, GA(G/A)GT(T/G/CJAAGAC(T/G/C)GT(T/GIC)GG(T/G/CJ-
GA; peptide 3, GDSFMIA; oligonucleotide 3 (reverse complement), 
GCCNGJATCAT(NG)AA(G/NC)(G/C)(T/A)(NG)TC(G/C/AlCC; peptide 
4, RVGIHTG; oligonucleotide 4 (reverse complement): CC(G/NC)GT(N 
G)TG{NG)AT(GINC)CC(G/NC)AC(G/NC)C(G/T). The degeneracies in 
these oligonucleotides were selected on the basis of the codon biases of 
previously sequenced Leishmania genes (18). The PCRs were performed 
in a total volume of 50 ,..,1 and contained 10 mM Tris, pH 8.3, 50 mM KCl, 
3 mM MgCl2 , 200 ILM each dNTP, 2 ILM each oligonucleotide, 2 ILg of 
genomic DNA from the Dl700 strain of L. donouani, and 1 unit of Taq 
Polymerase (Promega). Each PCR was performed on a Perkin Elmer 
DNA Thermal Cycler utiHzing 30 cycles with a 95 oc melting temper-
ature for 1 min, a 30 oc annealing temperature for 90 s, a 72 oc extension 
temperature for 1 min, with a final incubation at 72 oc for 5 min. 
1 The abbreviations used are: RAC, receptor-adenylate cyclase pro-
tein; rae, receptor-adenylate cyclase gene or mRNA; PCR, polymerase 
chain reaction; bp, base pairs; CFTR, cystic fibrosis transmembrane 
conductance regulator; kb, kilobase(s). 
Isolation of Adenylate Cyclase Cosmid Clones-A library generated 
from a Sau 3A partial digest of genomic DNA from L. donouani strain 
Dl700 and cloned into the cosmid vector SuperCos1 (Stratagene) was 
obtained from Dr. Buddy Ullman (Oregon Health Sciences University, 
Portland, OR) and screened with the 175-bp PCR product obtained 
using oligonucleotides 1 and 3. The product of this PCR was purified by 
phenol-chloroform extraction, and -150 ng was radiolabeled with 
[a-32[P]dATP (New England Nuclear) using random oligonucleotide 
priming (19). Four nylon filters (Schleicher and Schuell) containing 
approximately 2,000 colonies each were screened by filter hybridization 
(20) uitlizing the radiolabeled PCR fragment at a concentration of 2 X 
105 counts/min ml- 1 , and eight positive clones were colony purified for 
further analysis. Two of these positive cosmid clones, AC6 and AC9, 
which contained between them the entire rae gene family, were selected 
for detailed analysis. 
DNA Sequencing-Segments ofthe AC6 and AC9 cosmids containing 
the coding regions of the rae-A and rac-B genes were subcloned into the 
plasmid vector Bluescript SK + (Stratagene), and nested deletions were 
prepared by digestion with exonuclease III as described previously (21). 
Single-stranded DNA was prepared from these deletions (22) and se-
quenced by the dideoxy chain terminating method (23), as described 
(21). In addition, some regions were sequenced utilizing synthetic oli-
gonucleotides complementary to known regions of sequence. All se-
quences were obtained from both strands of the DNA. The partial 
sequences of RAC-C and RAC-D were obtained from double-stranded 
plasmid DNA using an A.L.F. automated DNA Sequencer (Pharmacia), 
and RAC-E partial sequence was obtained from double-stranded DNA 
by manual sequencing. 
Adenylate Cyclase Probes-The AC-B probe was a 1.9-kbPstl restric-
tion fragment from rac-B encoding amino acids 545-1174 (Fig. 1). This 
probe contains part of the conserved adenylate cyclase catalytic domain 
and part of the extracellular domain ofRAC-B. The 1.4-kb AC-CD probe 
representing the conserved adenylate cyclase catalytic domain of 
RAC-A was prepared using the PCR and a forward primer (20-mer) 
initiating immediately downstream from the second putative trans-
membrane segment (II in Fig. 1) and a reverse primer initiating at the 
RAC-A stop codon and proceeding upstream for 20 nucleotides. The 
probes for the 3'-untranslated regions of rae-A and rac-B were a 1.0-kb 
EcoRI!Sali fragment and a 410-bp NheiiXhoi fragment, respectively, 
initiating -100 bp downstream from each stop codon. Hybridizations of 
Southern and Northern blots were performed in 50% formamide, 5 xx 
SSC, 10 x Denhart's solution, 0.1% SDS, 5 mM EDTA at 42 °C, and 
washes were performed in 0.1 x SSC, 0.1% SDS, 5 mM EDTA at 55 °C. 
Expression of rae-A and rac-B mRNAs in Xenopus oocytes-For ex-
pression of rae mRNAs, the protein coding regions of rae-A and rac-B 
were subcloned into the oocyte expression vector pL2-5 (24). Capped 
transcripts were synthesized from these vectors utilizing T7 RNA po-
lymerase as described previously (25). Approximately 0.5 ng of each 
transcript, as well as 2.5 ng of transcript from a similar plasmid con-
taining the coding region of the CFTR chloride channel, were injected 
into defolliculated stage V-VI oocytes from X. laeuis as detailed previ-
ously (25). After 4-5 days of incubation at 17 oc in ND-96 buffer 
containing 96 mM NaCl, 2 mM KCl, 1.8 mM CaCI2 , 1 mM MgCl2 , 5 mM 
HEPES, pH 7.4, membrane currents were measured from each oocyte 
using the two-microelectrode voltage clamp technique (26). 
Construction of a Dominant Negative Deletion Mutant of rae-A-For 
expression of a dominant negative version of the RAC-A protein, RAC-
AA, the plasmid containing the rae-A insert within the pL2-5 plasmid 
was digested with Xhol, religated, and transformed into bacteria. Plas-
mids prepared from individual colonies were tested by restriction di-
gestion to identify those which were missing the terminal 0.7-kb Xhol 
fragment and hence were missing the sequence encoding the 218 
COOH-terminal amino acids of RAC-A. This plasmid was transcribed 
with T7 RNA polymerase, and the RNA was microinjected into oocytes 
as described above. 
cAMP Assays-Quantitation of cAMP was performed using the ra-
dioimmunoassay kit from Biomedical Technologies Inc. and the manu-
facturer's instructions. Oocytes were injected with 5 ng of either RAC-A 
or RAC-B cRNA and incubated in ND-96 for 3 days. Lysates were 
prepared from 15 oocytes containing each RNA and from 15 uninjected 
oocytes as follows. Each batch of oocytes was homogenized in 270 ,..,1 
10% trichloroacetic acid using a pestle and a microcentrifuge tube. This 
homogenate was clarified by centrifugation for 5 min in an Eppendorf 
microcentrifuge (Brinkmann Instruments, Inc.) for 5 min at 14,000 
revolutions/min. The supernatant was extracted three times with 5 vol-
umes of water-saturated ether, residual ether was removed by heating to 
50 oc for 30 min, and the samples were stored at -20 °C. Aliquots of each 
lysate were diluted and assayed in duplicate by radioimmunoassay. 
FIG. 1. Comparison of deduced 
amino acid sequences for RAC-A and 
RAC-B and alignment with T. brucei 
GRESAG4.3. Numbers at the right spec-
ify the last amino acid in each line. Verti-
cal lines indicate identical amino acids. 
Predicted (42) transmembrane segments 
I and II are indicated by underlining. The 
alignments were generated using the pro-
gram PILEUP (43). 
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GRESAG 4. 3 ----- ---MIARVCRLTKHSKfPHI PITT T'J'pTI EI WI,YI.LQLHPICVLV- ---- ---NVDDGGGVTVKAISLLYS-RKWNVKVINAVNAGLNASLAA 82 
I I Ill I I II I I 
RAC-A --- -MAMQIRPSLGGCLRHGGAG-DHAARRLSRLRAAKVf'YPTAV-VCYI I CCAPW\fMAFITNDAEREPVYILNAMYSTEAYTNEDAI<ALW'TGMDMAFYN 94 
I I I I I Ill I I I I 1111 111111 I IIlii I I I 
RAC-8 MYADATHPRRACWCGAGGVSGCVRQRHAYRCSRI.I acyr I IIJGAT TI TLA\'STVPAAWAAGAVASSDEPVYLLNAMYSLSDYNAKHAl<ALWLGIDSALHA 100 
t 
GRESAG 4. 3 RNWTVAPGVNVEVVRPPSYDIDPAQFLDVYLKVLNDDKSLLWLGPMGND--DAEKLYDTLEENRLVGFGPM'I'VSTRHEGYMPHLYFLRPEATGESYCPS 180 
1 I I I I I II 1111 I I I I I II I I I 
RAC-A SHYKAAGGRPIKILHPDPDQDNLYDIAEVILHSLARQEKLLAVLGPYLDGRLTAALSNADWQSGLMLIAPFTGSSGVRTWSDSVYFTRAEPMVELKWL 194 
I II 111111 Ill I I II I I I II I Ill I II I I 1111 111111 I I II 1111 I 
RAC-B VGYTAARGRPIKIIEPDPT-DDLSDIVAWLKALKDYPTLLGVIGPYSDTRLGAVLISPEIQNSGLMFLGPFTGSSSMRAWNENLYFMRAEPRLEIMAMV 199 
GRESAG 4. 3 TLCGESLRVLRQGFMYLDGLLGGSEAYDHAVDFISRMGYSFCCVFTVEDKAGGQGGSSEEFDAVWDEFAGGNPQAVIMFATMKPDAKKFLVRLVSDPRTE 280 
II I II I I I I I II I Ill I Ill I I II 1111 
RAC- A MH IVNRLRARRVAFMRLTGMHFGGEELTYVQDTLTSLLRDPAVLYTVPYSESSVEVDEEAFDAM--- -ADTNPQVI IVWAAPVOO.VIYFLEKVLTDPRTS 2 9 0 
II I 1111 Ill Ill I I Ill II I II I I IIIII Ill IIIII I I II I 11111111 
RAC-B KH IANTFRARRTAFMYLTGEQYGSFEHKSLVELMTSLSLDPPAVYSASYS -TSTAVNMTAFDAM--- -ADTRPQVI I IWG IPAGQVEELLKWLTDPRTS 294 
GRESAG 4. 3 DTFVLTPIFLQKSIVSIWKETLEEANVPLHPHRVIQTGSNPLAKEDYIDAIKRFQTEMRNYLTEYKEWSGF-- -NDADHF-- ------------------ 357 
I I I I I I II I I 
RAC- A SAYVISCSMIQRWFDVYKRLLSAGS IKPQOOR ILASATTSPVSGEGLKYMEVLKAQMSNYIENSGSFD---YYPDDDSTETLGRKARSEAPLSRKYTVD 3 8 7 
Ill I I II I II I II I Ill I I Ill I I I l I 
RAC- B SAY IMPSF ALQQMTFQVYYDLAMAGKLTPVDGQ I ISSATSFPLTEPASVHLRVFRAQMGEYMVKTGRVDASLWADEAKAVQQYGPWEHEASSSDSAAYVN 3 9 4 
GRESAG 4. 3 -- -LKNDADGELMVNGWIAGEVLRRALRSHGWMNTATAFLESLYEQRRYVI-DDIWGDFGGECDSFTSANGATCRCNRGGKNVYMREIAEDYRLQPLVG 453 
II II I I I I I I II I I II II I II I II II 
RAC-A EFFQAHPSIAKLMALGWLSGTLVQQTLEQTDWIVNRSTYKAGLFNQNRFVIGGDYVLGDYGGPCEPLAQFLGASCYCNQGGHSSIL'IVLQNASW-DIVPD 486 
II II II II II I Ill I II I I I I I I 111111111 I 1111 111111111 I I I I 
RAC-E NFFNEHPCVTQLMIAGWISGSLIAQTLAEENRIANRTAYRQYMFSQQRYIVGEDFVLGDYGGPCNGVAEFLGAVCYCNQGGHSAVLSRLDRAVW-TVITE 493 
GRESAG 4. 3 GHIMTTPLQCHIDPSILRPPLTGLTVDMEDHEELLRGSTQFETGVS'M'TSSG--KAGEMNSFFLQKWTDTQKVSNELNTLRQERIVTAVFGIVTKAVLG 551 
I I I I I I I II I I 
RAC- A SSFKYPQSECNSSKSQIVKAVSVLALLNQGYPKL IDAGMQLNEVLPHAFDDNLCKGYKVSSIFLRVETAKAQQLFDAEVS- -- -NYSVDI IAGPIFQALD 582 
I I I I I I I I I I I I I II II I I 
RAC-E SGVSFTQKNCYSDGTTLPRPLNFLTLIFAEHPLLAQVGLTFKTSISTLVAYLQYNASPVNAATVNVTDTI'PQALHDAVTT---- NYTTDWVGVTVKGMN 589 
GRESAG 4. 3 LPGLTFIDPITPTPHLNSFSRNVIHLSPTLEQQLYVLVNYLSSIRA---- -DFPNCVIRG-- -GEAPAI IDALRKTLVTFGLNLSSTWLTPGDTVGEHL 643 
I I I II I 111111 II I I II I I I II II I I I I 
RAC-A VGEIFVLNPLYNHPQLRTEKRNYVYLMPTLEQQIYVMYSKIDALRTRTDVFEDTAWLRGYSAQEWEISEILFKTAGTFNLPDPSVATISFTDSLRGLL 682 
I I I I I 1111111111111 I I I I I I II II I I I I Ill I I I I 
RAC~E VOOYLVPSPIHPRPHLVELLRNYVYLMPTLEQQMFVLYAKLSAVRGVTSIDSAVHMILHGYASDEVANITAVLRKSAATFNYDNPTVTAVPSTKTVGSAL 689 
GRESAG 4. 3 PKSGITFI IGLAVDDIWIEEHLRIHTKARVLVQFSDIALLYNEFVQAFNNSDGA- -KHLLFATSLPHWADVDTTSETVRR--- -FHEAVREVEKWTPLS 737 
I II I I I I I I I I I I Ill I I II II 
RAC-A SPRAINWIGMKDGDSAHFANFLAKYTDVMVV\!CFDELTMYYEELRATFSVQPTSVQARLMSFSSLPLWTDASAEAKARWPILGHFHKIFPDPINHTPSL 782 
II I I I II II II I I I I IIIII I 1111 I I I I I II Ill Ill 
RAC-8 AHGQINFVLAVTAPJJVADIVDFLVEEKTSIWIVFDDLVIQYPTLVTALKSKPASVQARVITFTNLPLWSDTSESAHAASKLLTVFHDALPDPSQHTPGF 789 
GRESAG 4 . 3 LLGFTTGRL IQENLQNMERVTSDLL VDLFFNQTVITIDDMHYGPYKHYDCI INGWTADDCM -ANFGATDISVWSMARALRSDEPLLQNPMSPSLVYTVP 8 3 6 
I Ill II I I I I I It I I I I I I I I I 
RAC- A LRDVI I AGF IQELVSTTTVAETKLLTNAvYINGGVTTYGFTLGNF -EWGC- -TATTSGDSCVYKNYGASNIE !LSIQRMLDPTVPQLSSPSTPTMEYRPR 87 9 
I I I II II I Ill I I Ill I I Ill 1111 I II 11111111111111 1111 1111 
RAC- B LSAVL TGSFCASMRRLADSVHSTSLTDMVYREGSVTTF AEPFGRF -QWGC- -TTTPTDRFCVYHNYGAQG IVMLSVQRMLDPTVPQLSSPMTPTMDYRPR 88 6 
GRESAG 4. 3 N -GNALTPAQLAGWGGSI FWA[ AJCI SVI ACFTLRGTRDNDSAPKEPTGPVTLIF'I'OIESSTALWAAHPDLMPDAVATHHRLIRSLITRYECYEVKTV 9 3 5 
111111 I I I I I II Ill 1111 1111111111111 I II II I Ill II I I 111111 
RAC-A QRSHALTPAQRNGLIAGCYVGAYYI IATCTI LLYCCMDNRNNDAAPKDGDEPVTLLFTDIESSTALWAALPQLMSDAIAAHHRVIRQLVKKYGCYEVKTI 979 
11111111111 I Ill I I I I 11111111111111111111111111111111111111111111111111111111111111111111 
RAC-E QRSHALTPAQRGGAIAGIAT I TVII I AVljGLALYCCMDNRNNDAAPKDGDEPVTLLFTDIESSTALWAALPQLMSDAIAAHHRVIRQLVKKYGCYEVKTI 986 
II 
GRESAG 4. 3 GDSFMIASKSPFAAVQLAQELQLRFLRLDWETNALDESYREFEEQRAEGECEYTPPTAHMDPEVYSRLWNGLRVRVGIHTGLCDIRYDEVTKGYDYYGRT 1035 
1111111 I II II I I I II I Ill IIIII I I 1111 I I II 111111111111 111111111111111 I 
RAC-A GDSFMIACRSAHSAVSLACEIQTKLLKHDWGTEALDRAYREFELARVDTLDDYEPPTARLSEEEYAALWCGLRVRVGIHTGLTDIRYDEVTKGYDYYGDT 1079 
1111111111111111111111111111111111111111111111111111111111111111111111111111111111111111111111111111 
RAC-E GDSFMIACRSAHSAVSLACEIQTKLLKHDWGTEALDRAYREFELARVDTLDDYEPPTARLSEEEYAALWCGLRVRVGIHTGLTDIRYDEVTRGYDYYGDT 1086 
GRESAG 4 . 3 SNMAARTESVANGGQVLMTHAAYMSLSGEDRNQLDVTTLGATVLRGVPEPVRMYQLNAVPGRNFAALRLDRELFNDGEDETTTSCSDHSSL---RAELS I 1132 
11111111 1111111 I II II I I I IIIII I I 11111111 1111 I I I I I I 
RAC- A SNMAARTEAVANGGQWATEAAWWALSNDERAG IAHTAMGPQGLRGVPFAVEMFQLNAVPGRRHAALRTEIEAILPDDTATDTASSAAGALLSSVETMSD 117 9 
11111111111111111111111111111111111111111111111111111111111111111111111111111111111111111111111 I 
RAC-E SNMAARTEAVANGGQVVATEAAWWALSNDERAG IAHTAMGPQGLRGVPFAVEMFQLNAVPGRRHAALRTEIEAI LPDDTATDTASSAAGALLSSVGTING 1186 
GRESAG 4. 3 AAQTIAASLQSLLGTFTPAQRQKALTPFCERCGVTLPRKMGHVWDNDSCQEVIRRIAAKVGHWDRHAAETRERSVCTLSS ------- -GSVI I ISNDL 1223 
I II I I Ill I I II I I I II I I I Ill 
RAC-A PAAGIAFVLASCFAPYPVAQRVRELQPLLSKWGVGAPPRSRLVSEEDYCQGLMNRLAIRIATVSQARLRLTREDAA-DGKFKLAS-SEALNPLAREGDSA 1277 
1111111111111111111111111111111111111111111111111111111111111111111 II I I I Ill II 
RAC-8 PAAGIAFVLASCFAPYPVAQRVRELQPLLSKWGVGAPPRSRLVSEEDYCQGLMNRLAIRIATVSQARCPVGNNGAAVDLDVQHAGTAEVMNPLLGEGSFI 1286 
GRESAG 4.3 SDMIRV-- --------------------- ---------------------- ------------------------- -------------- 1229 
1 
RAC- A AGGVRPRLPGSPVTSLP AGGSSSMREWRVFTRLMNDTQHPSVTHLSQQRPSNLTSFTEAQDAAFPLNAHCGPESRVENSGADDEE IVIVRVSRNPHY ARH 13 7 7 
I I I I I I II II I I 
RAC-B SOOARARHSGLTAVP- PSAEPSAMRMRRVGRKV-- -PERPTVCNVRGAH- --------------------- --------------------------- 13 31 
GRESAG 4. 3 
RAC-A AFE 1380 
RAC-B 
Cloning and Sequencing of Adenylate Cyclase Genes from 
Leishmania donovani-A PCR-based strategy was used to 
clone receptor-adenylate cyclase genes from L. donovani based 
on the assumption that they would contain sequences related 
to those found in the highly conserved catalytic domains of the 
trypanosome proteins (9, 10). We chose four highly conserved 
peptides (see "Experimental Procedures") present in the 
trypanosome cyclases in order to design degenerate oligonu-
cleotide primers (oligonucleotides 1-4). When these oligonu-
cleotides were used in the PCR (27) in conjunction with 
genomic DNA from L. donovani, L. mexicana, or L. enriettii, 
they amplified DNA fragments of sizes 175 bp (oligonucleotides 
1 and 3), 275 bp (oligonucleotides 2 and 4), and 400 bp (oligo-
nucleotides 1 and 4) (data not shown). These are the sizes of 
fragments that would be predicted for PCR amplification from 
DNA sequences closely related to the catalytic adenylate cy-
clase domains of the trypanosome genes, and these results 
suggested that L. donovani does contain genes related to the 
trypanosome adenylate cyclases. 
To determine the detailed structure of the Leishmania genes, 
we radiolabeled the 175-bp PCR fragment and used this rea-
gent as a probe to screen a cosmid library of L. donovani 
genomic DNA. Two hybridizing cosmid clones, designated AC6 
and AC9, were chosen for detailed structural analysis. The 
results of this analysis (see below and Fig. 3B) reveal that these 
two overlapping clones contain five clustered adenylate cyclase 
genes. Two of these genes, designated rae-A and rac-B, were 
then chosen for complete sequence analysis. The DNA sequence 
for each of these genes has been entered into the GenBank data 
base (rae-A and rae-B), and deduced protein sequences of rae-A 
and rac-B and their alignments with the T. brucei receptor-
adenylate cyclase GRESAG4.3 (9) are shown in Fig. 1. The 
sequences of the RAC-A (1380 amino acids) and RAC-B (1331 
amino acids) proteins clearly reveal that they are members of 
the receptor-adenylate cyclase family and are closely related in 
sequence and structure to the trypanosome proteins that are 
members of this family. RAC-A and RAC-B both contain: (i) a 
putative transmembrane segment near the NH2 terminus (un-
derlined sequences marked I in Fig. 1), (ii) a large (approxi-
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mately 830 amino acid) hydrophilic domain that follows this 
first transmembrane segment, (iii) a second putative trans-
membrane segment (underlined sequence marked II in Fig. 1), 
and (iv) a COOH-terminal hydrophilic domain with a high 
degree of identity to the conserved catalytic domain of eukary-
otic adenylate cyclases. In addition to these structural similar-
ities, there is a high degree of sequence identity between the 
trypanosome proteins and the RAC-A and RAC-B proteins. 
Direct comparison between each of the three proteins indicates 
that RAC-A is 30.6% identical to the T. brucei GRESAG4.3 
receptor-adenylate cyclase, RAC-B is 31.2% identical to this 
trypanosome protein, and RAC-A is 55.5% identical to RAC-B. 
The highest degree of identity occurs over the conserved cata-
lytic domains which are 52.7% identical between RAC-A and 
GRESAG4.3, 52.4% identical between RAC-B and GRE-
SAG4.3, and 88.0% identical between RAC-A and RAC-B. 
Within the putative extracellular domains, the identities be-
tween the RAC-A, RAC-B, and GRESAG4.3 are clustered in 
islands of high identity separated by stretches of low identity. 
There are several other structural features that are worthy 
of comment. First, it is not clear whether the first putative 
transmembrane segment is retained in the mature proteins 
and tethers the NH2 terminus to the membrane or whether it 
is cleaved during maturation of the polypeptide, as is the case 
in the structurally related atrial natriuretic peptide receptor 
(14). However, analysis of these sequences using von Heijne's 
algorithm (28) reveals a high similarity to known signal se-
quence cleavage sites at residue 53 ofRAC-A and 59 ofRAC-B, 
suggesting that these NH2-terminal hydrophobic sequences 
may be removed during processing. Second, RAC-A and RAC-B 
both contain multiple consensus sequences for asparagine-
linked glycosylation (29) (not shown), both in the putative 
extracellular domains and within the RAC-A conserved cata-
lytic domain. However, the extent to which the RAC-A and 
RAC-B proteins are modified by glycosylation is currently un-
known. Finally while the adenylate cyclase catalytic domains 
are highly conserved, the extreme COOH terminus of RAC-A 
(amino acids 1307-1380) and RAC-B (amino acids 1315-1331) 
bears no similarity to each other, suggesting that antibodies 
directed against these sequences should be able to specifically 
recognize each distinct isoform and may be useful for studies on 
subcellular localization of each protein. 
Functional Expression of RAC-A and RAC-B Proteins in Xe-
nopus oocytes-Although the rae-A and rac-B genes encode 
proteins with pronounced sequence similarity to known adeny-
late cyclases, it is nonetheless important to demonstrate exper-
imentally that these Leishmania proteins possess adenylate 
cyclase activity. A strategy that was employed successfully 
with the adenylate cyclase genes from T. brucei and T. equiper-
dum was to complement a temperature sensitive adenylate 
cyclase mutant of S. cerevisiae by transformation with the 
trypanosome gene and demonstrate the ability of the recombi-
nant yeast to grow at the non-permissive temperature. How-
ever, in similar experiments, we were unable to complement 
either temperature-sensitive or missense mutants of the yeast 
cyr 1 adenylate cyclase gene; hence, we attempted expression of 
rae-A and rac-B in Xenopus oocytes. This novel approach in-
volves co-expression of the rae gene with -the human CFTR 
gene, which encodes a chloride channel that is stimulated by 
phosphorylation of its regulatory domain via the cAMP-acti-
vated protein kinase A (30). Hence, if the rae genes encode 
functional adenylate cyclases, their co-expression in oocytes 
with CFTR will increase the intracellular cAMP, activate pro-
tein kinase A, stimulate the chloride channel activity of CFTR, 
and induce an increased current of Cl- ions that can be meas-
ured by voltage clamping the oocytes. The results of one such 
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FIG. 2. Adenylate cyclase activity of rae-A expressed in Xeno-
pus oocytes. A, the cAMP-mediated activation of the CFTR Cl- chan-
nel was measured by a two-electrode voltage clamp experiment. Oo-
cytes were injected with RNA encoding CFTR alone (squares), RAC-A 
alone (open circles), RAC-A plus CFTR !filled circles), or uninjected 
controls (crosses). After incubation for 4-5 days, each oocyte was im-
paled with two electrodes and continually superfused with ND96 buffer. 
Each data point represents the steady state current (mean ± S.E., n = 
3-4) at the indicated potential. Currents were recorded during a 250 ms 
pulse from a holding potential of -60 mV to the indicated test potential. 
B, the level of cAMP present in uninjected (nude) oocytes or in oocytes 
injected with 5 ng of cRNA encoding RAC-A (RAC-A), RAC-B (RAC-B), 
or RAC-AL\ (RAC-AL\), or with cRNAs encoding both RAC-A and RAC-B 
(RAC-A + RAC-B), or RAC-A and RAC-M (RAC-A + RAC-AL\) was 
measured by radioimminoassay. The measurements were performed on 
lysates from 15 pooled oocytes of each type and represent the averages 
of two cAMP determinations. The largest difference between duplicates 
was in the RAC-A expressing oocytes, where the standard deviation was 
135 pmol oocyte_,_ 
experiment are shown in Fig. 2A. Oocytes that were injected 
with both rae-A and CFTR mRNAs (filled circles) exhibited 
increased transmembrane conductance compared to oocytes 
that were uninjected (crosses), injected with CFTR mRNA only 
(squares), or injected with rae-A mRNA only (open circles). This 
conductance increase exhibited a reversal potential of -25 to 
-30 mV, corresponding to the Cl- equilibrium potential in 
Xenopus oocytes. This result strongly suggests that the RAC-A 
protein does possess adenylate cyclase activity which results in 
a CFTR-mediated Cl- conductance increase. It is noteworthy 
that this adenylate cyclase activity is present in the absence of 
any exogenous ligands which might bind to the RAC-A extra-
cellular domain and stimulate catalytic activity. A similar ob-
servation of enzymatic activity in the absence of added ligands 
was also reported for the trypanosome proteins expressed in 
yeast (10, 11). Co-injection of several batches of oocytes with 
mRNAs encoding the rac-B protein and the CFTR protein pro-
duced no statistically significant increase in Cl- conductances. 
These results suggest the possibility that there is no basal 
enzymatic activity ofRAC-B in the absence of ligand or that it 
is significantly lower than that of RAC-A. 
To confirm the results obtained by electrophysiology, we 
have assayed oocytes expressing RAC-A and RAC-B by a more 
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conventional radioimmunoassay (Fig. 2B). This quantitation 
reveals that rae-A-injected oocytes accumulate significantly 
more cAMP than control uninjected oocytes but that cAMP 
levels are not elevated in rac-B injected oocytes. Furthermore, 
co-expression of RAC-A and RAC-B in the same oocytes led to 
a marked attenuation of the adenylate cyclase activity com-
pared to the level observed in RAC-A expressing oocytes. To 
confirm that attenuation of RAC-A activity was not simply due 
to some contaminant in rac-B RNA which either degraded 
rae-A cRNA or inhibited its translation, we co-expressed rac-B 
RNA with cRNA encoding a Leishmania myo-inositol trans-
porter. The co-expressing oocytes exhibited myo-inositol trans-
port activity that was equivalent to that of oocytes injected with 
the transporter RNA only (data not shown); hence, the rac-E 
RNA does not contain an inhibitor that prevents expression of 
other co-injected RNAs. The inhibition or the RAC-A adenylate 
cyclase by RAC-B has been confirmed in three independent 
experiments and suggests that the RAC-B protein may interact 
with the RAC-A protein to negatively regulate its adenylate 
cyclase activity. 
Expression of a Dominant Negative Form of RAC-A- Domi-
nant negative forms of many signal transduction receptors can 
be prepared by expressing truncated proteins containing dele-
tions in the cytoplasmic domain involved in transducing the 
signal (31). Thus, deletion of part of the guanylate cyclase 
domain of the ANP receptor generates a truncated receptor 
that oligomerizes with the wild type protein and inhibits the 
guanylate cyclase activity of the complex (32). We have pre-
pared a truncated version of the rae-A gene that encodes a 
receptor, the RAC-M protein, that terminates at amino acid 
1162 of the RAC-A protein and which is missing the last 218 
amino acids of the adenylate cyclase catalytic domain. Co-
expression of this truncated receptor with the wild type RAC-A 
protein (Fig. 2B, RAG-A + RAC-A6.) markedly inhibits the 
adenylate cyclase activity of RAC-A. In control experiments 
similar to those described above, the co-expression of rac-A6. 
RNA with inositol transporter RNA failed to inhibit functional 
expression of the transporter protein. Hence RAC-A6. functions 
as a dominant negative receptor, strongly suggesting that the 
wild type and deleted proteins physically interact in the oocyte 
membrane. 
Genomic Arrangement of rae Genes-The existence of related 
but distinct rae-A and rac-B genes raises the question of how 
many members there are within this gene family. Since the 
catalytic domains of rae-A and rac-B are highly conserved, as is 
the case for adenylate cyclase genes in other eukaryotes (33), a 
probe containing this domain should be able to detect other 
family members. Consequently, we utilized a 1.9-kb Pstl frag-
ment from rac-B (AC-B probe) containing part ofthis conserved 
domain to probe a Southern blot containing Pstl digests of L. 
donouani genomic DNA and of AC6 and AC9 cosmid DNA. This 
blot (Fig. 3A) reveals five distinct bands of hybridization in 
genomic DNA marked A through E; bands A-D are also present 
in AC9 DNA, and bands B, C, and E are present in AC6 DNA. 
(In this nomenclature, the bands designated A and B are those 
derived from the rae-A and rac-B genes, respectively.) These 
results imply that the AC6 and AC9 inserts overlap, .and that 
these cosmids contain between them all five hybridization 
bands present in the genomic DNA. This pattern suggests that 
the L. donouani genome contains at least five a deny late cyclase 
genes which are clustered together and hence present on two 
overlapping cosmid clones. Clustered arrays of functionally 
related genes are common among the kinetoplastid protozoa 
such as Leishmania and Trypanosoma and appear to comprise 
single transcription units which are synthesized as polycis-
tronic precursor RNAs (34). 
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FIG. 3. Genomic arrangement of rae genes in L. donovani. A, 
Southern blot showing Pstl digested DNA from L. donouani strain 
DI700 genomic DNA (genomic) or from cos mid clones AC9 and AC6. The 
blot was probed with the 1.9-kb Pstl fragment of rac·B encoding part of 
the conserved adenylate cyclase catalytic domain (AC-B probe, "Exper-
imental Procedures"). Numbers (kilobase pairs) at the left indicate 
the mobility of DNA molecular weight markers. Letters A-E indicate the 
five hybridizing Pstl fragments present in both genomic DNA and in the 
cosmid inserts. B , restriction map of the rae gene cluster indicating 
the exact (rac·A and rac·B ) or approximate (rac-C, rac·D and rac-E) 
locations of the rae gene coding regions. The restriction map wa gen-
erated from single and multiple digestions with different restriction 
enzymes (A, Asel; B, Bglii; D, Dral; E , EcoRI; N , Notl; P, Pst l ; S , Spel). 
Sites with asterisks denote a pat"tial restriction map for this enzyme, 
indicating that other sites exist within the insert which have not been 
mapped. Hatched bars at the top of the figure indicate the positions of 
the inserts for the AC6 and AC9 cosmid clones. The open letters A·E 
underneath the restriction map define the location of the rae-A through 
rac-E genes. The positions of the coding regions of rae-A and rac·B (open 
boxes ) are known precisely from the restriction maps and the DNA 
sequence of these coding region . The arrows underneath these boxes 
indicate the direction of transcdption for these genes. The position of 
the 2.7-kb Pstl fragment containing the adenylate cyclase conserved 
catalytic domain of rac·E (black box) is known because a Pstl restriction 
fragment of this size that hybridizes to an adenylate cyclase catalytic 
domain probe (AC-CD probe, "Experimental Procedures") is present at 
this location in the restriction map. Hence, this box defines the approx-
imate position of the adenyl ate cyclase domain of rae· E. The 1.6-kb Pstl 
fragment from rac-C is located between the EcoRI site and the right 
hand terminus of AC6; this region is shown as a cross· hatched box. The 
1.2-kb Pstl restriction fragment from rac-D that hybridizes to the ad-
enylate cyclase probe is contained within the EcoRI!Bglii restt;ction 
fragment of AC9, but is not present in AC6; hence, its approximate 
location is also hown as a cross-hatched box. 
To further investigate the arrangement of the multiple rae 
genes, we have constructed a restriction map of the AC6 and 
AC9 inserts, and we have mapped the locations of the adeny-
late cyclase genes by hybridization of restriction fragments to a 
second probe (AC-CD probe) derived exclusively from the con-
served catalytic domain (Fig. 3B). This restriction map con-
firms that AC6 and AC9 do overlap and defines the precise 
location of rae-A and rac-B as well as the approximate locations 
of three other rae genes, designated rac-C, rac-D, and rac-E. 
Thus the open boxes in Fig. 3B represent the protein coding 
regions of rae-A and rac-B , as defined by the sequences of the 
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FIG. 4. Partial deduced amino acid 
sequences derived from cloned Pstl 
fragments encoding RAC-C, RAC-D, 
and RAC-E. Each subcloned Pstl insert 
was partially sequenced from each termi-
nus, and the deduced amino acid se-
quences were aligned with either RAC-A 
or RAC-B. In addition, an internal seg-
ment of the RAC-E insert was sequenced 
using an internal oligonucleotide primer. 
Amino acid identities are indicated by 
vertical lines. These sequences aligned 
with either the extracellular domain 
(RAC-C aligned maximally with RAC-A, 
whereas RAC-D and RAC-E aligned max-
imally with RAC-B) (A) or the catalytic 
adenylate cyclase domain ofRAC-B (B). A 
schematic diagram (C) shows the regions 
ofRAC-A and RAC-B that are homologous 
to the sequenced segments of RAC-C, 
RAC-D, and RAC-E. ECD refers to the 
extracellular domain, TMD to the trans-
membrane domain, and ACD to the ad-
enylate cyclase catalytic domain. 
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subclones and the locations of specific restriction sites. These 
results also define the direction of transcription for these two 
genes (arrows under each gene) and the probable direction for 
transcription of the gene cluster. Together, these results sug-
gest that there are five related rae genes located within this 
single cluster. 
To confirm the existence of three additional rae genes, we 
subcloned the Pstl fragments containing rac-C, rac-D, and 
rac-E and obtained partial DNA sequence from the termini of 
these subclones. The deduced amino acid sequences derived 
from one terminus of each subclone show pronounced similar-
ity to the extracellular domains ofRAC-A and RAC-B (Fig. 4A), 
TMD 
COOH 
whereas the deduced amino acid sequence derived from the 
other terminus of each clone shows identity to the adenylate 
cyclase catalytic domain of RAC-B (Fig. 4B). The similarities 
between each of the RAC proteins is shown schematically in 
Fig. 4C. These results confirm that each of these genomic 
fragments represents another rae gene and that there are five 
tandemly arrayed genes in this cluster. The limited sequence 
from RAC-E is identical to the corresponding regions ofRAC-B, 
suggesting that these two proteins may be very closely related 
to each other; however, the presence of an additional Pstl site 
in rac-B reveals that there is at least one polymorphism at the 
DNA level that generates the two differently sized rac-B and 
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FIG. 5. Northern blots showing expression of rae mRNAs in 
promastigotes and amastigotes of L. donovani. Total RNA (10 !J-g) 
from promastigotes (P ) and amastigotes (A ) of the LV9 strain of L . 
donouani was separated on a 1.2% agarose-formaldehyde gel , blotted 
onto a nylon filter, and hybridized with probes representing the adeny-
late cyclase conserved catalytic domain (AC, hybridized with the AC-CD 
probe), or the 3' -untranslated regions of rae-A (rae-A) or rac-B (rae-B). 
To demonstrate that lanes contained similar amounts of total RNA, one 
of these blots was rehybridized with a rRNA (44) probe (rRNA). Num-
bers at the left indicate the mobility of RNA molecular weight markers 
indicated in kilobases. 
rac-E Pstl fragments observed on the genomic Southern blot 
(Fig. 3A). 
Furthermore, the concordance between the five hybridizing 
Pstl fragments present in genomic DNA (Fig. 3A) and the five 
hybridizing Pstl fragments present in the AC6 and AC9 cosmid 
clones suggests that either: (i) this cluster contains all the 
adenylate cyclase genes present in the L. donovani genome, or 
that (ii) any other adenylate cyclase genes that might exist do 
not hybridize to the probe containing the conserved catalytic 
domain under the hybridization conditions used here and 
hence are relatively divergent in sequence. Another result 
which is consistent with a single clustered arrangement of 
adenylate cyclase genes is the observation (not shown) that 
Southern blots from pulsed-field gels (35) of L. donouani chro-
mosomes reveal a single band of hybridization to the adenylate 
cyclase probe representing a chromosome of - 850 kilobase 
pairs. 
Expression of rae mRNAs during the Leishmania Life Cy-
cle- To define the expression of the rae-A and rac-B mRNAs 
during the parasite life cycle, we have hybridized Northern 
blots containing equal amounts of total promastigote and 
amastigote RNA with probes representing the conserved ad-
enylate cyclase catalytic domain and the unique 3' -untrans-
lated regions of each mRNA (Fig. 5). These blots reveal that the 
rae-A ( - 9 kb) and rac-B ( - 5 kb) mRNAs are expressed in 
promastigotes but are not detectable in amastigotes; hence, 
these are developmentally regulated mRNAs. Rehybridization 
of these blots with a rRNA probe confirms that similar amounts 
of promastigote and amastigote RNA were present in each 
lane. The conserved adenylate cyclase catalytic probe hybrid-
izes to bands of sizes - 5, - 7, and - 9 kb, revealing that there 
are at least three different adenylate cyclase mRNAs. This 
probe also hybridizes to a - 5 kb band present at a low level in 
the amastigote RNA, suggesting that one of the rac-C, -D , or-E 
mRNAs may be expressed in amastigotes and may comigrate 
with the rac-B mRNA. 
DISCUSSION 
The results presented here demonstrate that Leishmania 
parasites possess a family of putative receptor-adenylate cycla-
ses that are related in structure to those described in the 
trypanosomes and that bear structural similarities to receptors 
with known ligands and functions from higher eukaryotes. 
Consequently, this family of probable receptors exists in kin-
etoplastid parasites that exhibit an intracellular mode of exist-
ence within their mammalian hosts and is not restricted to 
trypanosomes that live free in the bloodstream or to Kineto-
plastida such as T. brucei and T. equiperdum that undergo 
antigenic variation as a mode of immune evasion. The two most 
significant questions that now require examination are: (i) 
what specific role do these putative receptors play in signal 
transduction, and (ii) what ligands do they recognize? 
One possible role for the RAC proteins in signal transduction 
could be to bind ligands present in the insect vector or inside 
the host macrophages and induce a life cycle switch by elevat-
ing intracellular cAMP. The potential analogy to T. cruzi, 
where peptide ligands present inside the insect gut activate 
parasite adenylate cyclase and promote the developmental 
transformation between non-infectious epimastigotes and in-
fectious metacyclics (8), is obvious. It may be possible to assess 
the role of the RACs in development or in other physiological 
processes by genetic approaches, either by performing targeted 
gene disruptions (36) of individual rae genes, or by generating 
dominant negative mutants of these genes and overexpressing 
these altered polypeptides within the parasites. Finally, exten-
sive studies on various RAC family members will be required to 
determine whether they all function in closely related signal 
transduction pathways and recognize different but possibly re-
lated ligands, or whether each RAC transduces a different signal 
with a distinct effect on parasite biochemistry and physiology. 
The observation that co-expression of RAC-B markedly in-
hibits the adenylate cyclase activity of RAC-A (Fig. 2B) sug-
gests an intriguing mechanism for receptor function. These two 
proteins may oligomerize in the membrane to maintain the 
innate adenylate cyclase activity ofRAC-A in a repressed state. 
This repression might then be relieved by binding of ligand to 
the hetero-oligomer. If this interpretation is correct, it should 
be possible to detect complexes between RAC-A and RAC-B 
using specific antibodies against each protein or by epitope 
tagging individual receptors (32). Furthermore, the observa-
tion that the truncated RAC-M protein functions as a domi-
nant negative receptor (Fig. 2B) strongly suggests that these 
proteins oligomerize within the membrane and can affect the 
catalytic function of other members of the complex. The devel-
opment of a dominant negative mutant of the rae-A gene also 
provides a genetic tool which may be used to illuminate the 
biological function of these receptors in the parasite. 
Ligands for orphan receptor-guanylate cyclases have been 
identified in several higher eukaryotes (37-40), usually by 
assaying crude extracts for ability to stimulate guanylate cy-
clase activity in a target tissue followed by biochemical purifi-
cation of the active peptide. By analogy, it may be possible to 
search for potential ligands for the RAC proteins by applying 
extracts of macrophages or of sandflies to intact parasites or to 
a heterologous system expressing individual rae genes and 
assaying for an increase in adenylate cyclase activity. The 
assay that we have used for detection of RAC-A adenylate 
cyclase activity involving activation of the co-expressed CFTR 
channel, or the more conventional radioimmunoassay, may be 
useful for identifying ligands for each putative receptor. Thus 
application of a mixture containing a ligand to oocytes express-
ing RAC-A or RAC-B or co-expressing both proteins may in-
crease the cAMP level above that observed in the absence of 
ligand. 
The observation that rae-A and rac-B mRNAs are detectable 
in promastigotes but not amastigotes implies that these puta-
tive receptors function either in the insect or during the trans-
formation between the insect and the macrophage stage of the 
parasite life cycle. If these proteins are involved in developmen-
tal transitions, they could function in the switch between non-
infectious procyclic and infectious metacyclic promastigotes (41), 
or they could promote the differentiation of promastigotes to 
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amastigotes by interacting with a ligand present in macrophages. 
Clearly many questions remain to be answered concerning 
the functions of the rae genes and their protein products. At 
present, the RACs represent orphan receptors identified by 
molecular genetics but with unknown biological functions. 
However, as the first putative signal transduction receptors 
identified in Leishmania or related kinetoplastids (9, 10), these 
proteins provide the opportunity to study signal transduction 
and its potential role in the life cycle of these medically impor-
tant and biologically interesting parasites. 
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